These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 1735695
1. NLA-1: a 2-nitroimidazole radiosensitizer targeted to DNA by intercalation. Denny WA, Roberts PB, Anderson RF, Brown JM, Phil D, Wilson WR. Int J Radiat Oncol Biol Phys; 1992; 22(3):553-6. PubMed ID: 1735695 [Abstract] [Full Text] [Related]
3. 5-Nitro-4-(N,N-dimethylaminopropylamino)quinoline (5-nitraquine), a new DNA-affinic hypoxic cell radiosensitizer and bioreductive agent: comparison with nitracrine. Wilson WR, Siim BG, Denny WA, van Zijl PL, Taylor ML, Chambers DM, Roberts PB. Radiat Res; 1992 Sep; 131(3):257-65. PubMed ID: 1438685 [Abstract] [Full Text] [Related]
8. Radiosensitization in vitro and in vivo by 3-nitrotriazoles. Shibamoto Y, Sakano K, Kimura R, Nishidai T, Nishimoto S, Ono K, Kagiya T, Abe M. Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1063-6. PubMed ID: 3744928 [Abstract] [Full Text] [Related]
9. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170). Murayama C, Suzuki A, Suzuki T, Miyata Y, Sakaguchi M, Tanabe Y, Tanaka N, Mori T. Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):575-81. PubMed ID: 2528527 [Abstract] [Full Text] [Related]
10. A fluorinated 2-nitroimidazole, KU-2285, as a new hypoxic cell radiosensitizer. Sasai K, Nishimoto S, Shimokawa K, Hisanaga Y, Kitakabu Y, Shibamoto Y, Zhou L, Wang J, Takahashi M, Kagiya T. Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1249-54. PubMed ID: 1828462 [Abstract] [Full Text] [Related]
11. NLP-1: a DNA intercalating hypoxic cell radiosensitizer and cytotoxin. Panicucci R, Heal R, Laderoute K, Cowan D, McClelland RA, Rauth AM. Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1039-43. PubMed ID: 2703383 [Abstract] [Full Text] [Related]
13. Hypoxia-selective radiosensitization of mammalian cells by nitracrine, an electron-affinic DNA intercalator. Roberts PB, Anderson RF, Wilson WR. Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Apr; 51(4):641-54. PubMed ID: 3495509 [Abstract] [Full Text] [Related]
14. Clinical trials of radiosensitizers: what should we expect? Brown JM. Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):425-9. PubMed ID: 6231272 [Abstract] [Full Text] [Related]
17. Metabolic rate modification of nitrotriazole radiosensitizers by sulfur substitution of side chain. Kagiya VT, Sugita T, Nishimoto S, Masuoka M, Zhou L, Abe M, Shibamoto Y, Sasai K. Int J Radiat Oncol Biol Phys; 1992 Mar; 22(3):597-600. PubMed ID: 1735698 [Abstract] [Full Text] [Related]
18. KIH-802, an acetohydroxamic acid derivative of 2-nitroimidazole, as a new potent hypoxic cell radiosensitizer: radiosensitizing activity, acute toxicity, and pharmacokinetics. Sasai K, Shibamoto Y, Takahashi M, Zhou L, Hori H, Nagasawa H, Shibata T, Inayama S, Abe M. Cancer Chemother Pharmacol; 1990 Mar; 26(2):112-6. PubMed ID: 2140730 [Abstract] [Full Text] [Related]
19. Radiosensitizing and cytotoxic properties of DNA targeted phenanthridine-linked nitroheterocycles of varying electron affinities. Cowan DS, Matejovic JF, Wardman P, McClelland RA, Rauth AM. Int J Radiat Biol; 1994 Dec; 66(6):729-38. PubMed ID: 7814971 [Abstract] [Full Text] [Related]
20. Targeting radiosensitizers to DNA by attachment of an intercalating group: nitroimidazole-linked phenanthridines. Cowan DS, Panicucci R, McClelland RA, Rauth AM. Radiat Res; 1991 Jul; 127(1):81-9. PubMed ID: 2068275 [Abstract] [Full Text] [Related] Page: [Next] [New Search]